Collaborative Studies on Angiogenesis and Diabetic Complications
The summary for the Collaborative Studies on Angiogenesis and Diabetic Complications grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Collaborative Studies on Angiogenesis and Diabetic Complications: -The purpose of this RFA is to enhance our understanding of the effects of Type 1 diabetes on the development of new blood vessels from preexisting vessels (angiogenesis), in order to open new therapeutic avenues to treat diabetic vasculopathies. This RFA seeks basic and clinical studies on the mechanisms of abnormal angiogenesis seen in the complications of diabetes in wound healing, nephropathy, neuropathy and peripheral, coronary and cerebral arterial diseases. -Applications are invited from multiple investigators conducting collaborative research projects that foster sharing of expertise between the angiogenesis and diabetes fields. -The participating institutes plan on contributing $3 million to fund 5-10 new R01 awards with project periods ranging from 2-4 years. -Non-profit or for-profit organizations are eligible, including public or private institutions and domestic and foreign institutions. -Investigators may submit more than one application as part of different collaborative groups. There should be no scientific or budgetary overlap. -The PHS 398 application can be obtained from http://grants.nih.gov/grants/funding/phs398/phs398.html -Telecommunications for the hearing impaired is available at: TTY 301-451-0088
| Federal Grant Title: | Collaborative Studies on Angiogenesis and Diabetic Complications |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-DK-04-022 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.83793.847 |
| CFDA Descriptions: | Heart and Vascular Diseases Research 93.847 Diabetes, Endocrinology and Metabolism Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Mar 17, 2005 |
| Posted Date: | Nov 09, 2004 |
| Creation Date: | Nov 09, 2004 |
| Archive Date: | Apr 16, 2005 |
| Total Program Funding: | $3,000,000 |
| Maximum Federal Grant Award: | $350,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | 5 |
| Cost Sharing or Matching: | 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders |
- Applicants Eligible for this Grant
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply. Foreign institutions/organizations considering applying to this RFA must demonstrate an ability to conduct the proposed study in the designated setting(s) as well as an ability to meet government clearance requirements.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster